THE CHEKING PROCESS – Some scientists are worried about the use of this new treatment. Would another solution, dual therapy, be more effective in the face of variants?
THE QUESTION. According to several scientists, the current variants (English, South African, Brazilian, etc.) could have developed in immunocompromised people treated with antibodies (recovered from cured patients). Are doctors playing sorcerer’s apprentice with monoclonal antibodies?
CHECKS. This is not a certainty and it was not the current treatments. However, studies on the monoclonal antibody bamlanivimab have shown the possible appearance of viral resistance, the more frequent the higher the dose administered. For this reason, the health authorities
This article is for subscribers only. You have 82% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Already subscribed? Log in